PMID: 16612464Apr 14, 2006Paper

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
Antonio Waldo ZuardiFrancisco S Guimarães

Abstract

A high dose of delta9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of delta9-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typical effects of the plant. This observation led us to suspect that CBD could have anxiolytic and/or antipsychotic actions. Studies in animal models and in healthy volunteers clearly suggest an anxiolytic-like effect of CBD. The antipsychotic-like properties of CBD have been investigated in animal models using behavioral and neurochemical techniques which suggested that CBD has a pharmacological profile similar to that of atypical antipsychotic drugs. The results of two studies on healthy volunteers using perception of binocular depth inversion and ketamine-induced psychotic symptoms supported the proposal of the antipsychotic-like properties of CBD. In addition, open case reports of schizophrenic patients treated with CBD and a preliminary report of a controlled clinical trial comparing CBD with an atypical antipsychotic drug have confirmed that this cannabinoid can be a safe and well-tolerated alternative treatment for schizophrenia...Continue Reading

References

Dec 28, 1977·Psychopharmacology·J M Monti
Jul 1, 1975·Clinical Pharmacology and Therapeutics·L E Hollister, H Gillespie
Jan 1, 1991·Psychopharmacology·A W ZuardiJ M Cunha
Nov 1, 1991·Pharmacology, Biochemistry, and Behavior·P ConsroeK Schram
Jan 1, 1990·Psychopharmacology·F S GuimarãesA W Zuardi
Oct 23, 1973·Psychopharmacologia·I G Karniol, E A Carlini
Jan 1, 1974·Psychopharmacologia·M FernandesR Hill
Sep 1, 1974·European Journal of Pharmacology·I G KarniolE A Carlini
Jun 1, 1972·British Journal of Pharmacology·G Jones, R G Pertwee
Dec 18, 1982·Lancet·D RottanburgR Elk
Mar 1, 1981·Biochemical Pharmacology·L M BornheimR Karler
Mar 1, 1996·Harvard Review of Psychiatry·R J Baldessarini, F I Tarazi
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·A J HampsonD Wink
Aug 26, 1999·Life Sciences·B R MartinR K Razdan
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·F M LewekeH M Emrich
Aug 16, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B K Lipska, D R Weinberger
Dec 1, 2001·Schizophrenia Research·U SchneiderH M Emrich
Oct 30, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·José Alexandre de Souza CrippaGeraldo Filho Busatto
May 26, 2004·Life Sciences·Viviane M C GuimarãesFrancisco S Guimarães
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Apr 21, 2005·European Journal of Pharmacology·Fabrício A Moreira, Francisco S Guimarães
Jun 22, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·David M GardnerPaul Waraich
Sep 24, 2005·Psychopharmacology·Erika TimbyInger Sundström Poromaa
Jan 13, 2006·Journal of Psychopharmacology·Antonio Waldo ZuardiJosé Alexandre S Crippa
Jan 1, 1993·Journal of Psychopharmacology·A W ZuardiF S Guimarães

❮ Previous
Next ❯

Citations

Sep 17, 2009·Psychopharmacology·H Valerie CurranPaul Fletcher
Nov 16, 2011·Psychopharmacology·Maha M ElBatshD A Kendall
Mar 10, 2012·Psychopharmacology·Nicole PesaNadia Solowij
Feb 4, 2010·European Archives of Psychiatry and Clinical Neuroscience·Patrik RoserGeorg Juckel
Aug 11, 2012·Journal of Neurology·Michael G SerpellChristine Collin
Mar 9, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Slava Rom, Yuri Persidsky
Sep 15, 2011·Neurotoxicity Research·Marcelo KwiatkoskiElaine Del-Bel
Aug 9, 2013·Neuropharmacology·Francisco Espejo-PorrasConcepción García
Apr 30, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Celia J A MorganH Valerie Curran
Mar 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Toby T Winton-BrownPhilip K McGuire
Apr 8, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Victoria S DaltonKaterina Zavitsanou
Jul 8, 2009·Journal of Experimental Botany·M David MarksRichard A Dixon
Apr 22, 2008·Addiction Biology·Fabrício A Moreira, Beat Lutz
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Jan 11, 2013·Biotechnology Research International·Neeharika SrivastavaBechan Sharma
Jun 23, 2010·Cell Communication and Signaling : CCS·Susanne A WolfGerd Kempermann
Jul 10, 2010·Substance Abuse Treatment, Prevention, and Policy·Chaturaka RodrigoSenaka Rajapakse
Jun 19, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Louisa Degenhardt, Wayne D Hall
Jan 16, 2013·Drug Metabolism and Pharmacokinetics·Rongrong JiangKazuhito Watanabe
Oct 12, 2011·Sports Medicine·Marilyn A HuestisOlivier Rabin
Jul 1, 2009·Indian Journal of Psychological Medicine·Chaturaka Rodrigo, Senaka Rajapakse
Jul 26, 2012·ISRN Pharmacology·Kyra-Verena SendtDerek K Tracy
May 30, 2013·Clinical Reviews in Allergy & Immunology·Kelly P OwenTimothy E Albertson
Dec 20, 2008·Neural Plasticity·F A MoreiraF S Guimarães
Jul 26, 2014·The Journal of Clinical Investigation·Attila OláhTamás Bíró
Apr 15, 2014·Sleep Medicine Reviews·Peter J GatesJan Copeland
Oct 31, 2014·Immunopharmacology and Immunotoxicology·A RibeiroJ Palermo-Neto
Apr 1, 2011·Expert Opinion on Drug Discovery·Radu TanasescuCris S Constantinescu
Dec 3, 2014·Pharmacology & Therapeutics·Dan I LubmanMurat Yücel
Mar 6, 2013·Neuroscience and Biobehavioral Reviews·Zoran VukadinovicIvana Rosenzweig
Sep 20, 2011·Pharmacology & Therapeutics·Andrew J HillGary J Stephens
Jun 28, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·S Lev-RanY Levkovitz
Feb 15, 2011·Drug and Alcohol Dependence·Susanna Every-Palmer
Feb 4, 2011·Drug and Alcohol Dependence·James Richard BurgdorfRosalie Liccardo Pacula
Jan 29, 2011·Journal of Pain and Symptom Management·Sara N Davison, Joseph S Davison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
Celia J A Morgan, H Valerie Curran
Progress in Neuro-psychopharmacology & Biological Psychiatry
F A MoreiraFrancisco S Guimarães
Psychopharmacology
Francisco S GuimarãesAntonio Waldo Zuardi
© 2022 Meta ULC. All rights reserved